WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke QVEKLY wurde als Wortmarke am 20.09.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1522059 |
| Länder | 
|
| Basismarke |
Nr. VA 2019 00739,
22. März 2019
|
| Anmeldedatum | 20. September 2019 |
| Ablaufdatum | 20. September 2029 |
Markeninhaber
Tuborg Boulevard 5
2900 Hellerup
DK
2900 Hellerup
DK
Markenvertreter
Vejlsøvej 51
8600 Silkeborg
DK
Waren und Dienstleistungen
05
Pharmaceutical preparations for the treatment of growth
disorders, pharmaceutical preparations for the treatment of
endocrine disorders, pharmaceutical preparations for the
treatment of bone disorders, pharmaceutical preparations for
the treatment of cancer, pharmaceutical preparations for the
treatment of infectious diseases; diagnostic preparations
for medical use, namely, diagnostic preparations for
identifying and detecting growth hormone deficiency,
endocrine disorders, bone disorders, cancer, and infectious
diseases
09
Computer software and computer programs for use in providing
medical advice and advice on medications for treatment,
patient assistance and health insurance in the field of
growth disorders, endocrine disorders, bone disorders,
cancer, and infectious diseases; computer application
software for mobile phones, tablet computers, handheld
computers and personal computers, namely a downloadable
software application for sharing information related to
growth disorders, endocrine disorders, bone disorders,
cancer, infectious diseases and the treatment of growth
disorders, endocrine disorders, bone disorders, cancer, and
infectious diseases for use by patients with growth hormone
disorders, hypoparathyroidism, skeletal dysplasia, and
diabetes in the medical field of growth disorders, endocrine
disorders, bone disorders, cancer, and infectious diseases;
computer application software for mobile phones, tablet
computers handheld computers and personal computers, namely,
software that coordinates the delivery of health care
services between health care providers, patients and those
parties responsible for the payment of health care services,
namely software that allows individuals seeking medical
education, information and services to locate a physician
and treatment facility in their geographic area for medical
treatment and allows physicians and health care
professionals to communicate their credentials and
specialization to patients and parties responsible for
payment of healthcare services; computer application
software for mobile phones, tablet computers, handheld
computers and personal computers, namely, software that
enables health care providers to monitor patients,
communicate clinical information relevant to a patient's
care, provide and exchange information concerning patients
and the health care services provided to patients;
downloadable software, software applications and mobile
applications for providing co-pay and other financial or
medical access support; downloadable computer software for
providing a communications platform enabling users to share
health and healthcare information; downloadable software,
software applications and mobile applications for the
measurement of height, weight, blood pressure, serum
calcium, blood glucose, and heart rate; downloadable
software, software applications and mobile applications for
providing, exchanging, retrieving and analyzing health and
healthcare information; software for medical purposes,
namely, for formatting, viewing and transmitting medical
data collected and stored on hormone injection pens and
pumps between injection pens and pumps and portable
electronic devices; computer application software for mobile
phones, tablet computers, handheld computers and personal
computers, namely a downloadable software application for
providing healthcare-related information, medication
reminders, and tracking medication dosing history; the
foregoing related to pharmaceutical preparations for the
treatment of growth disorders, endocrine disorders, bone
disorders, cancer, and infectious diseases
10
Medical devices for injection, dosage and control of
pharmaceuticals, namely medical devices for injection,
dosage and control of pharmaceuticals for the treatment of
growth disorders, endocrine disorders, bone disorders,
cancer, and infectious diseases; syringes for medical
purposes and for injections; syringes for injection for
medical and surgical use, namely syringes in the form of
pens for surgical use; digitally connected medical devices
for monitoring the dosage of pharmaceutical preparations for
use in connection with management of growth hormone
disorders, hypoparathyroidism, skeletal dysplasia, cancer
and diabetes; medical apparatus, namely, infusion and
injection devices for administering drugs; medical apparatus
and instruments for diagnostic purposes for use in dosage
management for medicines containing software for medical
information management for use in web-based physical and
psychological examination and assessment of patients
remotely and in a clinic; medical apparatus for use in
dosage management of medicines, incorporating software for
medical information management for guidance and control of
medicines and for therapeutic use in web-based physical and
psychological examination and assessment of patients
remotely and at a clinic
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 21. Oktober 2021 | 2021/42 Gaz | JP | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 15. Juni 2021 | 2021/28 Gaz | RAW: Limitation | |
| 29. April 2021 | 2021/17 Gaz | JP | Ablehnung |
| 01. April 2021 | 2021/14 Gaz | KR | Ablehnung |
| 11. März 2021 | 2021/10 Gaz | NO | Ablehnung |
| 26. Januar 2021 | 2021/4 Gaz | CH | Ablehnung |
| 15. September 2020 | 2020/38 Gaz | AU | Ablehnung |
| 25. August 2020 | 2020/35 Gaz | CN | Ablehnung |
| 28. Juli 2020 | 2020/31 Gaz | NZ | Ablehnung |
| 03. April 2020 | 2020/15 Gaz | Korrektur | |
| 20. September 2019 | 2020/11 Gaz | DK | Eintragung |
ID: 141522059